50
Participants
Start Date
June 22, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
December 31, 2026
Doxycycline 40 MG ( 20mg twice daily)
Submicrobial dose doxycycline (40mg) to be administered as 20mg twice daily
Doxycycline 200 MG ( 100 mg twice daily)
200 mg dose doxycycline to be administered as 100mg twice daily
Placebo
Placebo to be administered in tablet form twice daily
University of California, San Farncisco, San Francisco
University of California, San Francisco
OTHER